Biochemical inhibition of the acetyltransferases ATase1 and ATase2 reduces β-secretase (BACE1) levels and Aβ generation.

Biochemical inhibition of the acetyltransferases ATase1 and ATase2 reduces β-secretase (BACE1) levels and Aβ generation.
复制标题

DOI:
10.1074/jbc.m111.310136
复制
发表时间:
2012-03-09
期刊:
The Journal of biological chemistry
影响因子:
--
通讯作者:
Puglielli L
Puglielli L
中科院分区:
其他
文献类型:
--
作者:
Ding Y;Ko MH;Pehar M;Kotch F;Peters NR;Luo Y;Salamat SM;Puglielli L

文献摘要

被引文献

相似文献

背景:乙酰转移酶ATase 1和ATase 2调节BACE 1的水平,参与阿尔茨海默病(Alzheimer disease,AD)的发病。结果:AD患者脑组织中两种AT酶均表达上调。鉴定了ATase 1/ATase 2抑制剂。构效关系,作用机制和生物效应进行了测定。结论:ATase 1/ATase 2抑制剂下调BACE 1的水平和活性。意义:ATase 1/ATase 2是预防AD的潜在靶点。β位点APP裂解酶1(BACE 1)是阿尔茨海默病(AD)淀粉样β肽(Aβ)生成的限速酶,其细胞水平受两种基于ER的乙酰辅酶A(赖氨酸乙酰转移酶,ATase 1和ATase 2)的严格调节。在这里,我们报告说,这两种乙酰转移酶都在神经元和神经胶质细胞中表达,并且在AD患者的大脑中上调。我们还报道了第一代和第二代化合物的鉴定,其抑制ATase 1/ATase 2并下调BACE 1的表达水平和活性。作用机制包括竞争性和非竞争性抑制以及产生不稳定的AT酶中间体,这些中间体进行降解。
Background: The acetyltransferases ATase1 and ATase2 regulate the levels of BACE1, which is involved in the pathogenesis of Alzheimer disease (AD). Results: Both ATases are up-regulated in the brain of AD patients. ATase1/ATase2 inhibitors were identified. Structure-activity relationship, mechanisms of action, and biological effects were determined. Conclusion: ATase1/ATase2 inhibitors down-regulate levels and activity of BACE1. Significance: ATase1/ATase2 are potential targets to prevent AD. The cellular levels of β-site APP cleaving enzyme 1 (BACE1), the rate-limiting enzyme for the generation of the Alzheimer disease (AD) amyloid β-peptide (Aβ), are tightly regulated by two ER-based acetyl-CoA:lysine acetyltransferases, ATase1 and ATase2. Here we report that both acetyltransferases are expressed in neurons and glial cells, and are up-regulated in the brain of AD patients. We also report the identification of first and second generation compounds that inhibit ATase1/ATase2 and down-regulate the expression levels as well as activity of BACE1. The mechanism of action involves competitive and non-competitive inhibition as well as generation of unstable intermediates of the ATases that undergo degradation.